About Bharat Serums & Vaccines Ltd
BSV has built a legacy of excellence over five decades, providing life-saving medicines and groundbreaking treatments to patients worldwide. Headquartered in Mumbai, India, and with state-of-the-art manufacturing facilities in Ambernath, Maharashtra, and Germany, BSV adheres to the highest international standards.
The company’s dedicated research and development (R&D) center in Mumbai employs over 60 scientists, focused on creating products that address unmet medical needs.
Product Portfolio
BSV offers a diverse range of biopharmaceutical products, catering to critical therapeutic areas:
1. Women’s Health and Fertility
- Innovative fertility hormones.
- Treatments addressing complications during pregnancy.
2. Critical Care and Emergency Medicine
- Antitoxins and anesthetics for life-threatening conditions.
- Plasma-derived therapies and immunoglobulins for immune support.
3. Anti-Infectives
- Antifungals and antibiotics for severe infections.
4. Specialized Biologics
- Monoclonal antibodies and other advanced biologics.
Manufacturing Excellence
BSV’s manufacturing facilities are recognized for their adherence to global standards.
Key Features:
- Global Manufacturing Practices (GMP): Ensuring high-quality production across all product lines.
- State-of-the-Art Technology: Advanced infrastructure for precision and efficiency.
- Global Distribution: Capable of meeting the demands of over 70 countries.
Global Reach
Bharat Serums & Vaccines Ltd has established a presence in more than 70 countries, with wholly-owned subsidiaries in the Philippines, Germany, and the USA. Through its extensive export network, BSV delivers life-saving medicines and health solutions to patients worldwide.
Research and Development
Innovation is the cornerstone of BSV’s success. The company’s R&D efforts are focused on:
- Developing novel biologics and plasma-based therapies.
- Improving fertility treatments and critical care solutions.
- Leveraging cutting-edge technology to address complex medical challenges.
With a robust R&D pipeline, BSV continues to create impactful healthcare solutions that improve lives globally.
Recent Milestones and Developments
1. Acquisition by Mankind Pharma
In October 2024, Mankind Pharma completed the acquisition of Bharat Serums & Vaccines for INR 13,768 Crores, marking a significant step in becoming a market leader in women’s health and fertility. This acquisition strengthens BSV’s position in the global pharmaceutical market.
2. Launch of NexoBrid
BSV partnered with MediWound to introduce NexoBrid, a groundbreaking treatment for severe burns. This innovative solution highlights BSV’s commitment to addressing critical healthcare needs.
Corporate Social Responsibility (CSR)
BSV actively contributes to community well-being through initiatives focused on:
- Improving public health and access to life-saving medicines.
- Promoting healthcare education and awareness.
- Implementing environmentally sustainable practices in its operations.
The company’s dedication to CSR reflects its commitment to creating a healthier, happier world.
Why Choose Bharat Serums & Vaccines Ltd?
- Innovative Products: Cutting-edge solutions across critical therapeutic areas.
- Global Standards: GMP-certified manufacturing and high-quality assurance.
- International Presence: Serving patients in over 70 countries.
- Research Excellence: A robust R&D pipeline focused on unmet medical needs.
- Community Impact: A strong emphasis on CSR and sustainability.
Conclusion
With over 50 years of innovation and excellence, Bharat Serums & Vaccines Ltd stands at the forefront of global healthcare. Through its pioneering products, advanced manufacturing, and unwavering commitment to quality, BSV continues to improve lives and redefine the pharmaceutical industry.